Skip to main content

Volume 15 Supplement 3

Sepsis 2011

Endotoxin removal by hemoperfusion in septic shock

Introduction

Many symptoms of septic shock are due to the presence of endotoxin in the bloodstream. The biological activity of endotoxins is associated with lipopolysaccharide (LPS). LPS induces systemic inflammatory response and a high level of endotoxin in blood is associated with worse clinical outcome. Reduction of the level of circulating endotoxins with hemoperfusion through the filter with high affinity for LPS could potentially interrupt the biological cascade of sepsis. The aim of the study was to evaluate the efficiency of extracorporeal endotoxin elimination in patients with Gram-negative septic shock.

Methods

The study was conducted at the Department of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Poland. Patients with septic shock, documented or suspected Gram-negative infection, and with high endotoxin activity (EA >0.6 units) were eligible for the study. The endotoxin activity in blood was measured with chemiluminescent activity assay. Based on the enrolment criteria and EA level, patients were assigned to the conventional treatment group (Group 1) or the conventional plus hemoperfusion therapy with LPS adsorber (Alteco Medical AB, Lund, Sweden) group (Group 2). Hemoperfusion was performed for 2 hours with blood flow maintained at 150 ml/minute.

Results

Seventeen patients with low EA (0.42 ± 0.14, Group 1) and 12 patients with high EA (0.76 ± 0.13, Group 2) (P < 0.05) were included. There were no significant differences between Group 1 and 2 regarding age (63 ± 2 and 61 ± 21), APACHE II score (22.7 ± 8.6 and 24.5 ± 7.2), SOFA score (9.8 ± 3.0 and 11.3 ± 4.1), mean arterial pressure (MAP, 66.2 ± 8.1 mmHg and 71.5 ± 7.3 mmHg), and PaO2/FiO2 (255 ± 59 and 216 ± 105) at entry to the study. In the hemoperfusion group, nine patients had Gram-negative and three had Gram-positive infection; seven patients survived to the 28-day follow-up. High endotoxin activity at baseline decreased significantly 24 hours after hemoperfusion to 0.5 ± 0.1 (P < 0.01) in those who survived, but remained high (0.7 ± 0.1) in nonsurvivors. At 24 hours after hemoperfusion, MAP significantly increased (78.8 ± 20.8 to 89.2 ± 19.8 mm Hg, P < 0.05) and vasopressor requirements decreased in survivors but not in those who died (MAP, 64.2 ± 9.6 to 71.8 ± 15.3 mm Hg, P = nonsignificant).

Conclusion

Hemoperfusion with LPS adsorber added to standard treatment improved the hemodynamic status of patients with septic shock. The chemiluminescence assay for measurement of LPS activity was a valuable diagnostic tool for rapid detection of endotoxemia.

Acknowledgements

The authors declare no conflict of interest related to this work. The study was supported by the Wroclaw Medical University. LPS adsorbers were kindly provided by Alteco Medical AB, Lund, Sweden.

Author information

Affiliations

Authors

Corresponding author

Correspondence to S Zielinski.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Adamik, B., Smiechowicz, J., Zielinski, S. et al. Endotoxin removal by hemoperfusion in septic shock. Crit Care 15, P7 (2011). https://doi.org/10.1186/cc10376

Download citation

Keywords

  • Septic Shock
  • Sofa Score
  • Valuable Diagnostic Tool
  • Endotoxin Activity
  • Conventional Treatment Group